Lytgobi (futibatinib) marks the first medicine launched by Taiho Oncology Europe in the UK (2) For United Kingdom (UK) Trade and Medical Media Only ...

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...

NEW DELHI, Aug. 9, 2021 /PRNewswire/ -- "Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity & Clinical Trials Insight 2026" Report Highlights ...

Investigators tested the diagnostic performance of Triage Plus for bladder cancer detection in a Veterans affairs population with hematuria.

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses Central confirmation of tumor ...

A new study published in the Journal of the American Medical Association showed that navepegritide significantly increased ...

The U.S. Food and Drug Administration on Tuesday extended its review of Ascendis Pharma's therapy for children with a rare ...